Covid-19. Covid-19 disease
Conditions
Interventions
Intervention 1: Intervention group: In addition to the standard treatment regimen for covid-19, capsules which have aqueous licorice extract containing 80 mg of the active ingredient glycyrrhizin w
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients diagnosed for coronavirus according to clinic such as fever, cough and mylagia Patients diagnosed for coronavirus according to paraclinic such as lymphopenia and increase of CRP Patients in the range of 18-65 years old
Exclusion criteria
Exclusion criteria: Sensitivity to licorice and it derivatives Patients with hepato, renal or respiratory disorders Patients who take cytotoxic or corticosteroid drugs Nursing or pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time interval until clinical symptoms improve. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: Time of recovery.;Lymphopenia. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: Cell counter device.;CRP level. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: CRP kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGholamreza Karimi
Mashhad University of Medical Sciences
Outcome results
None listed